Radiation therapy regulates TCF-1 to maintain CD8+T cell stemness and promotes anti-tumor immunotherapy

被引:9
|
作者
Wang, Bin [1 ]
Hu, Jing [1 ]
Zhang, Jian [2 ]
Zhao, Lina [1 ]
机构
[1] Air Force Med Univ, Xijing Hosp, Dept Radiat Oncol, 15 West Changle Rd, Xian 710032, Peoples R China
[2] Air Force Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China
关键词
Radiotherapy; TCF-1; Stem CD8+T; cGAS; STING; TME; CD8(+) T-CELLS; RADIOTHERAPY; MICROENVIRONMENT; IMMUNITY; TRIAL;
D O I
10.1016/j.intimp.2022.108646
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Radiotherapy is a very effective cancer treatment, mainly through inducing DNA damage of cancer cells. Meanwhile, there is evidence that irradiation can also mobilize tumor-specific immunity, and recent investigations demonstrate that the efficiency of local high-dose radiotherapy is attributable to the presence of CD8+T cells. Here, we observed that high-dose radiation remarkably increased the enrichment of stem cell-like CD8+T cells. Moreover, cGAS/STING signaling augmented stem cell-like CD8+T cells and T stem-like central memory CD8+T cells in a mice tumor model after radiation. These findings raise our understanding of stem celllike CD8+T cells after radiation stimulation and improve radiation therapy by driving the cGAS/STING signaling pathway for cancer multimodality therapy.
引用
收藏
页数:6
相关论文
共 46 条
  • [41] Rescue of Notch-1 Signaling in Antigen-Specific CD8+ T Cells Overcomes Tumor-Induced T-cell Suppression and Enhances Immunotherapy in Cancer
    Sierra, Rosa A.
    Thevenot, Paul
    Raber, Patrick L.
    Cui, Yan
    Parsons, Chris
    Ochoa, Augusto C.
    Trillo-Tinoco, Jimena
    Del Valle, Luis
    Rodriguez, Paulo C.
    CANCER IMMUNOLOGY RESEARCH, 2014, 2 (08) : 800 - 811
  • [42] Local TLR4 stimulation augments in situ vaccination induced via local radiation and anti-CTLA-4 checkpoint blockade through induction of CD8 T-cell independent Th1 polarization
    Jagodinsky, Justin C.
    Bates, Amber M.
    Clark, Paul A.
    Sriramaneni, Raghava N.
    Havighurst, Thomas C.
    Chakravarty, Ishan
    Nystuen, Erin J.
    Kim, KyungMann
    Sondel, Paul M.
    Jin, Won Jong
    Morris, Zachary S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [43] The induction of tumor-specific CD4+ T cells via major histocompatibility complex class II is required to gain optimal anti-tumor immunity against B16 melanoma cell line in tumor immunotherapy using dendritic cells
    Fujisawa, Yasuhiro
    Nabekura, Tsukasa
    Nakao, Tomohei
    Nakamura, Yasuhiro
    Takahashi, Takenori
    Kawachi, Yasuhiro
    Otsuka, Fujio
    Onodera, Masafumi
    EXPERIMENTAL DERMATOLOGY, 2009, 18 (04) : 396 - 403
  • [44] SHMT2 regulates CD8+ T cell senescence via the reactive oxygen species axis in HIV-1 infected patients on antiretroviral therapy
    Zhang, Qi-Sheng
    Wang, Jia-Ning
    Yang, Tian-Ling
    Li, Si-Yao
    Liu, Ding-Ning
    Shang, Hong
    Zhang, Zi-Ning
    EBIOMEDICINE, 2025, 112
  • [45] Improved Natural Killer cell activity and retained anti-tumor CD8+ T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy
    Muraro, E.
    Comaro, E.
    Talamini, R.
    Turchet, E.
    Miolo, G.
    Scalone, S.
    Militello, L.
    Lombardi, D.
    Spazzapan, S.
    Perin, T.
    Massarut, S.
    Crivellari, D.
    Dolcetti, Riccardo
    Martorelli, D.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [46] CK2B Induces CD8+ T-Cell Exhaustion through HDAC8-Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti-PD-1 Therapy in Non-Small-Cell Lung Cancer
    Liu, Shaochuan
    Ma, Shiya
    Liu, Gen
    Hou, Lingjie
    Guan, Yong
    Liu, Liang
    Meng, Yuan
    Yu, Wenwen
    Liu, Ting
    Zhou, Li
    Yuan, Zhiyong
    Pang, Shuju
    Zhang, Siyuan
    Li, Junyi
    Ren, Xiubao
    Sun, Qian
    ADVANCED SCIENCE, 2025,